EUVIMEDEUVIMED entdecken
Crossref

Tannic Acid–Iron Complex-Based Nanozyme Ameliorates Parkinson’s Disease via Relieving Oxidative Stress and Neuroinflammation

Wenya He, Mengyao Liu, Tongyu Zhang, Yajing Sun, Yaping Wang, Hongyang Wu, Meng Zheng iD, Bingyang Shi iD, Yan Zou iD

ACS Nano · 23.09.2025 · 19 (37) · 33212-33229

DOI: 10.1021/acsnano.5c07601 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 11.09.2025. Verfasst von Wenya He und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Zhongzhou Laboratory for Integrative Biology, Henan Key Laboratory of Brain Targeted Bio-nanomedicine, School of Pharmacy, Henan University, Kaif…. Hauptthemen laut MEDLINE: Tannins, Oxidative Stress, Parkinson Disease, Iron. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: Natural Science Foundation of Henan Province, China Postdoctoral Science Foundation, Postdoctoral Innovation Project of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxidative stress (OS)-induced neuronal damage and neuroinflammation form a vicious cycle that promotes the progression of Parkinson's disease (PD). Herein, a therapeutic strategy exploiting the tannic acid (TA)-iron (Fe) complex-based nanoparticles (BSA/Fe-TA NPs) that simultaneously relieves brain OS and neuroinflammation is developed for PD therapy. BSA/Fe-TA NPs possess atomically dispersed iron catalytic active sites and display multienzyme-like activities, which can efficiently scavenge reactive oxygen/nitrogen species (RONS). Moreover, they are able to penetrate the blood-brain barrier (BBB) and accumulate in neurons and microglia, thereby mitigating OS in the brain microenvironment via efficient intracellular and extracellular RONS elimination and regulating the polarization of microglia into the anti-inflammatory M2-phenotype to relieve neuroinflammation. After systemic administration, BSA/Fe-TA NPs significantly ameliorate PD progression in a mouse model without inducing adverse effects. Moreover, BSA/Fe-TA NPs can be degraded with the assistance of the clinical iron-chelating ligand deferoxamine, thus accelerating their elimination in vivo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TanninsOxidative StressParkinson DiseaseIronNanoparticlesNeuroinflammatory DiseasesAnimalsMiceHumansBlood-Brain BarrierMaleDisease Models, AnimalPolyphenols

Stichwörter der Autor:innen

Parkinson’s diseaseneuroinflammationoxidative stresssingle-atom catalytic sitestannic acid−iron complex-based nanozyme

Substanzen

TanninsIrontannic acidPolyphenols

Autor:innen und Institutionen

  • The Zhongzhou Laboratory for Integrative Biology, Henan Key Laboratory of Brain Targeted Bio-nanomedicine, School of Pharmacy, Henan University, Kaifeng, Henan 475004, China.
  • Henan-Macquarie University Joint Centre for Biomedical Innovation, Henan Key Laboratory of Brain Targeted Bio-nanomedicine, School of Life Sciences, Henan University, Kaifeng, Henan 475004, China.
  • School of Biomedical Engineering, University of Technology Sydney, New South Wales 2007, Australia.
  • Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney NSW 2109, Australia.

ORCID-Profile: Meng Zheng, Bingyang Shi, Yan Zou

Förderung

  • Natural Science Foundation of Henan Province
  • China Postdoctoral Science Foundation
  • Postdoctoral Innovation Project of Shandong Province
  • National Natural Science Foundation of China
  • Henan University
  • Key Technologies Research and Development Program of Henan
  • Henan Province Science and Technology Research and Development Program Joint Fund (Advantage Discipline Cultivation) Project

Zitieren

APA

He, W., Liu, M., Zhang, T., Sun, Y., Wang, Y., Wu, H., Zheng, M., Shi, B., & Zou, Y. (2025). Tannic Acid–Iron Complex-Based Nanozyme Ameliorates Parkinson’s Disease via Relieving Oxidative Stress and Neuroinflammation. ACS Nano, 19(37), 33212-33229. https://doi.org/10.1021/acsnano.5c07601

Vancouver

He W, Liu M, Zhang T, Sun Y, Wang Y, Wu H, et al. Tannic Acid–Iron Complex-Based Nanozyme Ameliorates Parkinson’s Disease via Relieving Oxidative Stress and Neuroinflammation. ACS Nano. 2025;19(37):33212-33229. doi:10.1021/acsnano.5c07601

BibTeX
@article{He2025,
  author = {He, Wenya and Liu, Mengyao and Zhang, Tongyu and Sun, Yajing and Wang, Yaping and Wu, Hongyang and Zheng, Meng and Shi, Bingyang and Zou, Yan},
  title = {Tannic Acid–Iron Complex-Based Nanozyme Ameliorates Parkinson’s Disease via Relieving Oxidative Stress and Neuroinflammation},
  journal = {ACS Nano},
  year = {2025},
  volume = {19},
  number = {37},
  pages = {33212--33229},
  doi = {10.1021/acsnano.5c07601}
}
Kostenlos starten →